157 related articles for article (PubMed ID: 30866526)
1. Gene Regulation by Antitumor
Khalid M; Idichi T; Seki N; Wada M; Yamada Y; Fukuhisa H; Toda H; Kita Y; Kawasaki Y; Tanoue K; Kurahara H; Mataki Y; Maemura K; Natsugoe S
Cancers (Basel); 2019 Mar; 11(3):. PubMed ID: 30866526
[TBL] [Abstract][Full Text] [Related]
2. Gene regulation by antitumor miR-130b-5p in pancreatic ductal adenocarcinoma: the clinical significance of oncogenic EPS8.
Fukuhisa H; Seki N; Idichi T; Kurahara H; Yamada Y; Toda H; Kita Y; Kawasaki Y; Tanoue K; Mataki Y; Maemura K; Natsugoe S
J Hum Genet; 2019 Jun; 64(6):521-534. PubMed ID: 30858505
[TBL] [Abstract][Full Text] [Related]
3. Regulation of actin-binding protein ANLN by antitumor
Idichi T; Seki N; Kurahara H; Yonemori K; Osako Y; Arai T; Okato A; Kita Y; Arigami T; Mataki Y; Kijima Y; Maemura K; Natsugoe S
Oncotarget; 2017 Aug; 8(32):53180-53193. PubMed ID: 28881803
[TBL] [Abstract][Full Text] [Related]
4. Molecular pathogenesis of triple-negative breast cancer based on microRNA expression signatures: antitumor miR-204-5p targets AP1S3.
Toda H; Kurozumi S; Kijima Y; Idichi T; Shinden Y; Yamada Y; Arai T; Maemura K; Fujii T; Horiguchi J; Natsugoe S; Seki N
J Hum Genet; 2018 Dec; 63(12):1197-1210. PubMed ID: 30228364
[TBL] [Abstract][Full Text] [Related]
5. Molecular Pathogenesis of Pancreatic Ductal Adenocarcinoma: Impact of
Tanaka T; Okada R; Hozaka Y; Wada M; Moriya S; Satake S; Idichi T; Kurahara H; Ohtsuka T; Seki N
Cancers (Basel); 2020 Sep; 12(10):. PubMed ID: 32977589
[TBL] [Abstract][Full Text] [Related]
6. The microRNA expression signature of pancreatic ductal adenocarcinoma by RNA sequencing: anti-tumour functions of the
Yonemori K; Seki N; Idichi T; Kurahara H; Osako Y; Koshizuka K; Arai T; Okato A; Kita Y; Arigami T; Mataki Y; Kijima Y; Maemura K; Natsugoe S
Oncotarget; 2017 Sep; 8(41):70097-70115. PubMed ID: 29050264
[TBL] [Abstract][Full Text] [Related]
7. Downregulated miR-98-5p promotes PDAC proliferation and metastasis by reversely regulating MAP4K4.
Fu Y; Liu X; Chen Q; Liu T; Lu C; Yu J; Miao Y; Wei J
J Exp Clin Cancer Res; 2018 Jul; 37(1):130. PubMed ID: 29970191
[TBL] [Abstract][Full Text] [Related]
8. Involvement of anti-tumor
Idichi T; Seki N; Kurahara H; Fukuhisa H; Toda H; Shimonosono M; Yamada Y; Arai T; Kita Y; Kijima Y; Mataki Y; Maemura K; Natsugoe S
Oncotarget; 2018 Jun; 9(48):28849-28865. PubMed ID: 29988949
[TBL] [Abstract][Full Text] [Related]
9. Dual strands of the miR-223 duplex (miR-223-5p and miR-223-3p) inhibit cancer cell aggressiveness: targeted genes are involved in bladder cancer pathogenesis.
Sugawara S; Yamada Y; Arai T; Okato A; Idichi T; Kato M; Koshizuka K; Ichikawa T; Seki N
J Hum Genet; 2018 May; 63(5):657-668. PubMed ID: 29540855
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-122-5p inhibits cell proliferation, migration and invasion by targeting CCNG1 in pancreatic ductal adenocarcinoma.
Dai C; Zhang Y; Xu Z; Jin M
Cancer Cell Int; 2020; 20():98. PubMed ID: 32256207
[TBL] [Abstract][Full Text] [Related]
11. MiRNA-615-5p functions as a tumor suppressor in pancreatic ductal adenocarcinoma by targeting AKT2.
Sun Y; Zhang T; Wang C; Jin X; Jia C; Yu S; Chen J
PLoS One; 2015; 10(4):e0119783. PubMed ID: 25856297
[TBL] [Abstract][Full Text] [Related]
12.
Fukuda K; Seki N; Yasudome R; Mitsueda R; Asai S; Kato M; Idichi T; Kurahara H; Ohtsuka T
Genes (Basel); 2023 Apr; 14(5):. PubMed ID: 37239355
[TBL] [Abstract][Full Text] [Related]
13. NR2F1-AS1 Promotes Pancreatic Ductal Adenocarcinoma Progression Through Competing Endogenous RNA Regulatory Network Constructed by Sponging miRNA-146a-5p/miRNA-877-5p.
Luo D; Liu Y; Li Z; Zhu H; Yu X
Front Cell Dev Biol; 2021; 9():736980. PubMed ID: 34650983
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-323-3p inhibits cell invasion and metastasis in pancreatic ductal adenocarcinoma via direct suppression of SMAD2 and SMAD3.
Wang C; Liu P; Wu H; Cui P; Li Y; Liu Y; Liu Z; Gou S
Oncotarget; 2016 Mar; 7(12):14912-24. PubMed ID: 26908446
[TBL] [Abstract][Full Text] [Related]
15. MiR-708-5p inhibits the progression of pancreatic ductal adenocarcinoma by targeting Sirt3.
Huang S; Guo H; Cao Y; Xiong J
Pathol Res Pract; 2019 Apr; 215(4):794-800. PubMed ID: 30683474
[TBL] [Abstract][Full Text] [Related]
16. MiR-345-5p functions as a tumor suppressor in pancreatic cancer by directly targeting CCL8.
Mou T; Xie F; Zhong P; Hua H; Lai L; Yang Q; Wang J
Biomed Pharmacother; 2019 Mar; 111():891-900. PubMed ID: 30841468
[TBL] [Abstract][Full Text] [Related]
17. The Interaction Between Long Non-coding RNA HULC and MicroRNA-622 via Transfer by Extracellular Vesicles Regulates Cell Invasion and Migration in Human Pancreatic Cancer.
Takahashi K; Koyama K; Ota Y; Iwamoto H; Yamakita K; Fujii S; Kitano Y
Front Oncol; 2020; 10():1013. PubMed ID: 32656089
[TBL] [Abstract][Full Text] [Related]
18. MiR-7-5p functions as a tumor suppressor by targeting SOX18 in pancreatic ductal adenocarcinoma.
Zhu W; Wang Y; Zhang D; Yu X; Leng X
Biochem Biophys Res Commun; 2018 Mar; 497(4):963-970. PubMed ID: 29408481
[TBL] [Abstract][Full Text] [Related]
19. miR-186 and 326 predict the prognosis of pancreatic ductal adenocarcinoma and affect the proliferation and migration of cancer cells.
Zhang ZL; Bai ZH; Wang XB; Bai L; Miao F; Pei HH
PLoS One; 2015; 10(3):e0118814. PubMed ID: 25742499
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of thymopoietin by miR-139-5p suppresses cell proliferation and induces cell cycle arrest/apoptosis in pancreatic ductal adenocarcinoma.
Zhou H; Zhang L; Tu H
Oncol Lett; 2019 Oct; 18(4):3443-3452. PubMed ID: 31516562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
